Non-ASH Events
November 6 - 10, 2024 | Houston, Texas
CAR-T cells vs T-cell engaging bispecifics in Hematological Malignancies
Join our session to explore the latest advancements in CAR-T cells and bispecific T-cell engagers for the treatment of hematological malignancies. Discover the unique advantages, challenges, and opportunities of these novel therapies in revolutionizing patient outcomes. Learn about the current innovation in cell therapy and drug design but also the specific adverse events of such constructs. Don't miss this opportunity to gain insights from leading experts in the field and to access the latest advances from selected SITC abstracts.
SITC 2024 is the largest conference focused solely on cancer immunotherapy, providing international leaders from academia, regulatory and government agencies, and industry representatives, with a multidisciplinary environment focused on improving outcomes for all cancer patients.